---
title: Your Monthly Cardiometabolic Brief
---

Industry Updates & Culinary Wellness...

| View in browser DECEMBER   DAPA-HF Study Illustrates Safety and Efficacy of Dapagliflozin In Heart Failure   In the recent DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure) study, Dapagliflozin reduced the risk of death and worsening heart failure and improved symptoms across the broad spectrum of age including elderly individuals.       COLCOT Trial Demonstrates Benefits of Colchicine after Myocardial Infarction   Recent findings from the Colchicine Cardiovascular Outcomes Trial found that among patients with a recent myocardial infarction, colchicine (an orally administered antiinflammatory medication indicated for the treatment of gout and pericarditis) at a dose of 0.5 mg daily led to much lower risk of ischemic cardiovascular events than placebo.       Effect of Intensive Blood Pressure Control on Lifespan With High CV Risk   Findings from the SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated that intensive blood pressure control (systolic BP target 120mmHg) was more effective to standard BP control (<140mmHg) in reducing cardiovascular events by 25% and mortality by 27% within middle aged and older adults at high CV risk.       Metformin decreases HF hospitalization risk in T2D patients   A retrospective cohort analysis published in the JAHA has found that metformin use is associated with a lower risk of heart failure hospitalization in patients with new‐onset type 2 diabetes. A 40% lower risk was observed among users in various models drawn from several matched cohorts.       Featured Recipe       Complimentary CME Activity       Best Blog Recently the FDA has stated to continue efforts “to bring competition to the insulin market to lower prices and expand access”, with biosimilar insulins taking center-stage READ MORE       Meet Our Planning Committee Meet Dr. Pamela B. Morris, MD--the current Director of Preventive Cardiology and the Seinsheimer Cardiovascular Health Program and Co-Director of Women's Heart Care at the Medical University of South Carolina. Among her many passions and accomplishments, Dr. Morris has had a career long interest in educating physicians and patients across the nation on sex-specific issues in cardiovascular care. READ BIO             Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700 Unsubscribe Manage preferences |
| --- |